These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28857430)

  • 1. Nonresolving macrophage-mediated inflammation in malignancy.
    Murray PJ
    FEBS J; 2018 Feb; 285(4):641-653. PubMed ID: 28857430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.
    Komohara Y; Fujiwara Y; Ohnishi K; Takeya M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):180-185. PubMed ID: 26621196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity.
    Wiehagen KR; Girgis NM; Yamada DH; Smith AA; Chan SR; Grewal IS; Quigley M; Verona RI
    Cancer Immunol Res; 2017 Dec; 5(12):1109-1121. PubMed ID: 29097420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma sensitive or chemoresistant to temozolomide differentially modulate macrophage protumor activities.
    Azambuja JH; da Silveira EF; de Carvalho TR; Oliveira PS; Pacheco S; do Couto CT; Beira FT; Stefanello FM; Spanevello RM; Braganhol E
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2652-2662. PubMed ID: 28713019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters.
    Szebeni GJ; Vizler C; Kitajka K; Puskas LG
    Mediators Inflamm; 2017; 2017():9294018. PubMed ID: 28197019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic features of macrophages in inflammatory diseases and cancer.
    Na YR; Je S; Seok SH
    Cancer Lett; 2018 Jan; 413():46-58. PubMed ID: 29100962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages as targets for tumor immunotherapy.
    Weigert A; Sekar D; Brüne B
    Immunotherapy; 2009 Jan; 1(1):83-95. PubMed ID: 20635976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging and cancer: The role of macrophages and neutrophils.
    Jackaman C; Tomay F; Duong L; Abdol Razak NB; Pixley FJ; Metharom P; Nelson DJ
    Ageing Res Rev; 2017 Jul; 36():105-116. PubMed ID: 28390891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent pathways of macrophage polarization: The role of B cells.
    Sica A; Porta C; Riboldi E; Locati M
    Eur J Immunol; 2010 Aug; 40(8):2131-3. PubMed ID: 20623553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.
    Mantovani A; Sica A; Allavena P; Garlanda C; Locati M
    Hum Immunol; 2009 May; 70(5):325-30. PubMed ID: 19236898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c.1085A>G Genetic Variant of
    Yeh YM; Hsu SJ; Lin PC; Hsu KF; Wu PY; Su WC; Chang JY; Shen MR
    Clin Cancer Res; 2017 Oct; 23(20):6021-6030. PubMed ID: 28724665
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytostatic cancer therapy modulates monocyte-macrophage cell functions: how it impacts on treatment outcomes.
    Patysheva M; Stakheyeva M; Larionova I; Fedorov A; Kzhyshkowska J; Cherdyntseva N
    Exp Oncol; 2019 Sep; 41(3):248-253. PubMed ID: 31569929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CCR5 Therapy Circumvents Immune Cell Exploitation by Tumors.
    Cancer Discov; 2016 Jun; 6(6):571. PubMed ID: 27125549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants.
    Schenkel LB; Molina JR; Swinger KK; Abo R; Blackwell DJ; Lu AZ; Cheung AE; Church WD; Kunii K; Kuplast-Barr KG; Majer CR; Minissale E; Mo JR; Niepel M; Reik C; Ren Y; Vasbinder MM; Wigle TJ; Richon VM; Keilhack H; Kuntz KW
    Cell Chem Biol; 2021 Aug; 28(8):1158-1168.e13. PubMed ID: 33705687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.
    Bonelli S; Geeraerts X; Bolli E; Keirsse J; Kiss M; Pombo Antunes AR; Van Damme H; De Vlaminck K; Movahedi K; Laoui D; Raes G; Van Ginderachter JA
    FEBS J; 2018 Feb; 285(4):777-787. PubMed ID: 28834216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological targets of metabolism in disease: Opportunities from macrophages.
    Castegna A; Gissi R; Menga A; Montopoli M; Favia M; Viola A; Canton M
    Pharmacol Ther; 2020 Jun; 210():107521. PubMed ID: 32151665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages: cancer therapy's double-edged sword.
    Brower V
    J Natl Cancer Inst; 2012 May; 104(9):649-52. PubMed ID: 22517985
    [No Abstract]   [Full Text] [Related]  

  • 19. Engineering macrophages and their derivatives: A new hope for antitumor therapy.
    Wei F; Liu H; Wang Y; Li Y; Han S
    Biomed Pharmacother; 2024 Aug; 177():116925. PubMed ID: 38878637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression.
    Weigert A; Mora J; Sekar D; Syed S; Brüne B
    Adv Exp Med Biol; 2016; 930():205-39. PubMed ID: 27558823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.